SCHEMBL1542477

SCHEMBL1542477

COc1c(NC(=O)c2ccc(NS(C)(=O)=O)cn2)cc(-c2ccc[nH]c2=O)cc1C(C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.59
MAPK14 Q16539 3/20 0.39
ABL1 P00519 2/20 0.38
PIK3CD O00329 2/20 0.37
CDC25A P30304 1/20 0.37
CDC25B P30305 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
CRBN Q96SW2 1/20 0.36
CDK9 P50750 1/20 0.36
LYN P07948 2/20 0.35
MAPK9 P45984 2/20 0.35
MAPK10 P53779 1/20 0.35
TRPV1 Q8NER1 2/20 0.34
FYN P06241 1/20 0.34
TGFBR1 P36897 1/20 0.34
ACVR1 Q04771 1/20 0.34
S1PR1 P21453 1/20 0.34
EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1764609 0.94 CYP3A4 (0.53) CYP3A4MAPK14ABL1PIK3CDCDC25A
SCHEMBL1542369 0.88 CYP3A4 (0.65) CYP3A4MAPK14ABL1CDK9MAPK10
SCHEMBL1542876 0.86 CYP3A4 (0.58) CYP3A4MAPK14CRBNTRPV1
SCHEMBL1542928 0.85 CYP3A4 (0.44) CYP3A4ABL1CDC25ACDC25B
SCHEMBL2129460 0.85 CYP3A4 (0.59) CYP3A4MAPK14ABL1CRBNMAPK10
SCHEMBL2127612 0.85 CYP3A4 (0.58) CYP3A4MAPK14ABL1CRBNTRPV1
SCHEMBL2128872 0.84 CYP3A4 (0.57) CYP3A4MAPK14ABL1CRBNTRPV1
SCHEMBL1542597 0.83 CYP3A4 (0.57) CYP3A4MAPK14CRBNTRPV1
SCHEMBL1542475 0.83 CYP3A4 (0.56) CYP3A4MAPK14CRBN
SCHEMBL2128420 0.82 CYP3A4 (0.53) CYP3A4MAPK14LYNMAPK9BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307372-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2012-04-25 EP claimed
EP-2307372-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2011-04-13 EP claimed